By Vijay Kumar MalesuReviewed by Susha Cheriyedath, M.Sc.Jul 3 2024 In a recent study published in the JAMA Network Open, researchers examined trends in new attention-deficit/hyperactivity disorder diagnoses, prevalence, and ADHD medication use in Finland from 2015 to 2022.
About the study The present study assessed new ADHD diagnoses, prevalence, and medication use using nationwide health register data in Finland from January 1, 2015, to June 30, 2022, with diagnoses tracked from January 1969 to June 2022. Ethical approval was granted by the Finnish National Institute for Health and Welfare, and informed consent was not required for anonymized data. The population included all individuals with a Finnish social security number during the study period.
Study results The nationwide study cohort comprised 5,572,420 Finland residents. In 2022, the mean age was 44.1 years, and 50.65% were women, with 229,753,086 observed person-years during follow-up.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: medical_xpress - 🏆 101. / 51 Read more »